News

If developed as a biopharmaceutical, this improved, highly stable version of IFN-gamma would allow less frequent injections of the drug. The novel molecules, developed using Nautilus’ proprietary technology

The review of serotonin-selective reuptake inhibitor (SSRI) and serotonin-norepinephrine reuptake inhibitor (SNRI) medicines looked at the potential risk of suicidal behavior in children and adolescents treated with these

The Ottawa Statement was published in the British Medical Journal (BMJ). It outlines three key principles for registration to help ensure clinicians, researchers, patients and the public have

The nanoparticles can reveal tiny cancerous tumors that are invisible by ordinary means of detection, according to the researchers at Washington University School of Medicine in St Louis.

The data were presented at the 75th European Atherosclerosis Society (EAS) Congress in Prague, the Czech Republic. The first presentation included new data from four studies (MERCURY II,

The European Commission will have 90 working days, subject to possible extensions, to issue an opinion on the matter. Johnson & Johnson and Guidant Corporation said that they

The two companies have signed a definitive agreement under which Shire has agreed to acquire TKT. Shire will pay $37 in cash for each share of TKT common

Temodal (temozolomide) is currently approved in the EU for the treatment of patients with malignant glioma such as glioblastoma multiforme (GBM), or anaplastic astrocytoma, showing recurrence or progression

Kali has been awarded 180 days of marketing exclusivity for being the first to file an abbreviated new drug application (ANDA) containing a paragraph IV certification for the